LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,520
تعداد مشاهده مقاله45,428,454
تعداد دریافت فایل اصل مقاله11,297,012
Deeb, Ali, Hamdoun, Said, Dababo, Khaled. (1388). Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis. سامانه مدیریت نشریات علمی, 6(3), 154-159.
Ali Deeb; Said Hamdoun; Khaled Dababo. "Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis". سامانه مدیریت نشریات علمی, 6, 3, 1388, 154-159.
Deeb, Ali, Hamdoun, Said, Dababo, Khaled. (1388). 'Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis', سامانه مدیریت نشریات علمی, 6(3), pp. 154-159.
Deeb, Ali, Hamdoun, Said, Dababo, Khaled. Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis. سامانه مدیریت نشریات علمی, 1388; 6(3): 154-159.

Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis

Iranian Journal of Immunology
مقاله 6، دوره 6، شماره 3، آذر 2009، صفحه 154-159    اصل مقاله (134.13 K)
نوع مقاله: Original Article
نویسندگان
Ali Deeb* 1؛ Said Hamdoun2؛ Khaled Dababo3
1Department of Internal Medicine
2Department of Rheumatology
3Department of Laboratory in Aleppo University, Aleppo, Syria
چکیده
Background: Antiphospholipid antibodies (aPL) are a heterogeneous family of anti-bodies associated with thrombosis and other complications.
Objective: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria.
Methods: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (aCL) and Lupus antico-agulant (LA) were determined.
Results: Thirty-four out of 157 (21.7%) patients with thrombosis had some type of aPL. aPL was also found in four healthy subjects (4/63=6.3%). Eighteen patients (11.5%) were positive for LA, 20 (12.7%) for aCL anti-bodies and 4 (2.6%) were positive for more than one aPL. Patients without risk factors for thrombosis and having positive aPL were 23/34 (67.7%). Fourteen out of 78 (17.9%) patients with arterial thrombosis, and 20/79 (25.3%) with venous thrombosis were positive for at least one aPL.
Conclusion: Our study showed a significant preva-lence of aPL in patients with thrombosis. It seems that aPL is a risk factor for venous and arterial thrombosis, especially in patients with no conventional risk factors.
کلیدواژه‌ها
Antiphospholipid Antibodies؛ Anticardiolipin Antibodies؛ SLE
آمار
تعداد مشاهده مقاله: 890
تعداد دریافت فایل اصل مقاله: 643


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب